The epidermal growth factor receptor (EGFR), the platelet-derived growth factor receptor (PDGFR), and the MET factor are the most commonly deregulated receptor tyrosine kinases (RTKs) associated with glioma [45]. Here, EGFR is linked to central nervous system cancer.